RASA3
Ras GTPase-activating protein 3
You are using an outdated browser. Please upgrade your browser to improve your experience.
Most Knowledge About | Knowledge Value
(0 to 1 scale) | ||
---|---|---|---|
molecular function | 0.94 | ||
protein domain | 0.92 | ||
transcription factor perturbation | 0.88 | ||
disease perturbation | 0.87 | ||
cell type or tissue | 0.7 | ||
These are targets about which virtually nothing is known. They do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
These targets do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
- OR - satisfy the following criterion:
Target has at least one ChEMBL compound with an activity cutoff of < 30 nM - AND - satisfies the preceding conditions
Target has at least one approved drug - AND - satisfies the preceding conditions
Click on a row in the table to change the structure displayed.
Data Source | Name | Explore in Pharos | Explore in Source | ||
---|---|---|---|---|---|
Reactome | Cytokine Signaling in Immune system | ||||
Reactome | Disease | ||||
Reactome | Diseases of signal transduction | ||||
Reactome | FLT3 Signaling | ||||
Reactome | Immune System | ||||
Name | Explore in Pharos | Explore in Source | ||
---|---|---|---|---|
Cytokine Signaling in Immune system | ||||
Disease | ||||
Diseases of signal transduction | ||||
FLT3 Signaling | ||||
Immune System | ||||
GO Term | Evidence | Assigned by | ||
---|---|---|---|---|
Inferred from Direct Assay (IDA) | BHF-UCL | |||
Traceable Author Statement (TAS) | ProtInc | |||
Inferred from Electronic Annotation (IEA) | UniProtKB-KW | |||
GWAS Trait | EFO ID | ENSG ID | Study Count | SNP Count | Beta Count | Odds Ratio | Evidence (Mean Rank Score) | Provenance | ||
---|---|---|---|---|---|---|---|---|---|---|
lymphocyte count | 3 | 6 | 7 | 98.5 | ||||||
lymphocyte count | 3 | 6 | 7 | 98.5 | ||||||
lymphocyte percentage of leukocytes | 1 | 3 | 3 | 90.9 | ||||||
lymphocyte percentage of leukocytes | 1 | 3 | 3 | 90.9 | ||||||
triglyceride measurement | 2 | 2 | 2 | 82.4 | ||||||
GWAS Trait | EFO ID | Beta Count | Odds Ratio | Evidence (Mean Rank Score) | Provenance | ||
---|---|---|---|---|---|---|---|
lymphocyte count | 7 | 98.5 | |||||
lymphocyte count | 7 | 98.5 | |||||
lymphocyte percentage of leukocytes | 3 | 90.9 | |||||
lymphocyte percentage of leukocytes | 3 | 90.9 | |||||
triglyceride measurement | 2 | 82.4 | |||||
Species | Name | Source ID | Gene ID | OMA | EggNOG | Inparanoid | ||
---|---|---|---|---|---|---|---|---|
Chimp | RAS p21 protein activator 3 | VGNC:14788 | 452684 | |||||
Macaque | RAS p21 protein activator 3 | 698964 | ||||||
Mouse | MGI:1197013 | 19414 | ||||||
Rat | RGD:69365 | 29372 | ||||||
Dog | RAS p21 protein activator 3 | VGNC:45361 | 476998 | |||||
Species | Name | OMA | EggNOG | Inparanoid | ||
---|---|---|---|---|---|---|
Chimp | RAS p21 protein activator 3 | |||||
Macaque | RAS p21 protein activator 3 | |||||
Mouse | ||||||
Rat | ||||||
Dog | RAS p21 protein activator 3 | |||||
PMID | Year | Title |
---|